BiVACOR Email Format

Medical Equipment ManufacturingCalifornia, United States51-200 Employees

BiVACOR is a clinical-stage medical device company focused on developing long-term therapies for patients with biventricular heart failure, including the BiVACOR Total Artificial Heart (TAH). It is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international offices in Gold Coast, Australia, and it employs between 51 and 200 people. The BiVACOR TAH is currently advancing through an FDA-approved first-in-human Early Feasibility Study under founder Daniel Timms, PhD, with guidance from cardiovascular surgeons William E. Cohn, MD, and O. H. (Bud) Frazier, MD. The device uses magnetic levitation technology with a magnetically suspended dual-sided rotor in two pump chambers, delivering pulsatile blood flow without valves and designed for a body surface area greater than 1.4 m2 to provide adequate cardiac output. In May 2025, BiVACOR received FDA Breakthrough Device Designation for its technology.

Get verified BiVACOR emails free

Company overview Employee directory